1JWH | A:; B: | CRYSTAL STRUCTURE OF HUMAN PROTEIN KINASE CK2 HOLOENZYME |
1NA7 | A: | CRYSTAL STRUCTURE OF THE CATALYTIC SUBUNIT OF HUMAN PROTEIN KINASE CK2 |
1PJK | A: | CRYSTAL STRUCTURE OF A C-TERMINAL DELETION MUTANT OF HUMAN PROTEIN KINASE CK2 CATALYTIC SUBUNIT |
2PVR | A: | CRYSTAL STRUCTURE OF THE CATALYTIC SUBUNIT OF PROTEIN KINASE CK2 (C-TERMINAL DELETION MUTANT 1-335) IN COMPLEX WITH TWO SULFATE IONS |
3AT2 | A: | CRYSTAL STRUCTURE OF CK2ALPHA |
3AT3 | A: | CRYSTAL STRUCTURE OF CK2ALPHA WITH PYRADINE DERIVATIVE |
3AT4 | A: | CRYSTAL STRUCTURE OF CK2ALPHA WITH PYRADINE DERIVERTIVE |
3BQC | A: | HIGH PH-VALUE CRYSTAL STRUCTURE OF EMODIN IN COMPLEX WITH THE CATALYTIC SUBUNIT OF PROTEIN KINASE CK2 |
3C13 | A: | LOW PH-VALUE CRYSTAL STRUCTURE OF EMODIN IN COMPLEX WITH THE CATALYTIC SUBUNIT OF PROTEIN KINASE CK2 |
3H30 | A:; B: | CRYSTAL STRUCTURE OF THE CATALYTIC SUBUNIT OF HUMAN PROTEIN KINASE CK2 WITH 5,6-DICHLORO-1-BETA-D-RIBOFURANOSYLBENZIMIDAZOLE |
3JUH | A:; B: | CRYSTAL STRUCTURE OF A MUTANT OF HUMAN PROTEIN KINASE CK2ALPHA WITH ALTERED COSUBSTRATE SPECIFICITY |
3MB6 | A: | HUMAN CK2 CATALYTIC DOMAIN IN COMPLEX WITH A DIFURANE DERIVATIVE INHIBITOR (CPA) |
3MB7 | A: | HUMAN CK2 CATALYTIC DOMAIN IN COMPLEX WITH A DIFURANE DERIVATIVE INHIBITOR (AMR) |
3NSZ | A: | HUMAN CK2 CATALYTIC DOMAIN IN COMPLEX WITH AMPPN |
3OWJ | A: | HUMAN CK2 CATALYTIC DOMAIN IN COMPLEX WITH A PYRIDOCARBAZOLE DERIVATIVE INHIBITOR |
3OWK | A: | HUMAN CK2 CATALYTIC DOMAIN IN COMPLEX WITH A BENZOPYRIDOINDOLE DERIVATIVE INHIBITOR |
3OWL | A: | HUMAN CK2 CATALYTIC DOMAIN IN COMPLEX WITH A BENZOPYRIDOINDOLE DERIVATIVE INHIBITOR |
3PE1 | A: | CRYSTAL STRUCTURE OF HUMAN PROTEIN KINASE CK2 ALPHA SUBUNIT IN COMPLEX WITH THE INHIBITOR CX-4945 |
3PE2 | A: | CRYSTAL STRUCTURE OF HUMAN PROTEIN KINASE CK2 IN COMPLEX WITH THE INHIBITOR CX-5011 |
3Q04 | A: | CRYSTAL STRUCTURE OF THE APO-FORM OF HUMAN CK2 ALPHA AT PH 8.5 |
3Q9W | A: | CRYSTAL STRUCTURE OF HUMAN CK2 ALPHA IN COMPLEX WITH EMODIN AT PH 8.5 |
3Q9X | A:; B: | CRYSTAL STRUCTURE OF HUMAN CK2 ALPHA IN COMPLEX WITH EMODIN AT PH 6.5 |
3Q9Y | A: | CRYSTAL STRUCTURE OF HUMAN CK2 ALPHA IN COMPLEX WITH QUINALIZARIN AT PH 8.5 |
3Q9Z | A:; B: | CRYSTAL STRUCTURE OF HUMAN CK2 ALPHA IN COMPLEX WITH QUINALIZARIN AT PH 6.5 |
3QA0 | A:; B: | CRYSTAL STRUCTURE OF THE APO-FORM OF HUMAN CK2 ALPHA AT PH 6.5 |
3R0T | A: | CRYSTAL STRUCTURE OF HUMAN PROTEIN KINASE CK2 ALPHA SUBUNIT IN COMPLEX WITH THE INHIBITOR CX-5279 |
3RPS | A:; B: | STRUCTURE OF HUMAN CK2ALPHA IN COMPLEX WITH THE ATP-COMPETITIVE INHIBITOR 3-(4,5,6,7-TETRABROMO-1H-BENZOTRIAZOL-1-YL)PROPAN-1-OL |
3U4U | A: | CASEIN KINASE 2 IN COMPLEX WITH AZ-INHIBITOR |
3U87 | A:; B: | STRUCTURE OF A CHIMERIC CONSTRUCT OF HUMAN CK2ALPHA AND HUMAN CK2ALPHA' IN COMPLEX WITH A NON-HYDROLYSABLE ATP-ANALOGUE |
3W8L | A:; B: | CRYSTAL STRUCTURE OF HUMAN CK2 IN COMPLEX WITH INOSITOL HEXAKISPHOSPHATE |
3WAR | A: | CRYSTAL STRUCTURE OF HUMAN CK2A |
4DGL | C:; D: | CRYSTAL STRUCTURE OF THE CK2 TETRAMERIC HOLOENZYME |
4FBX | A: | COMPLEX STRUCTURE OF HUMAN PROTEIN KINASE CK2 CATALYTIC SUBUNIT CRYSTALLIZED IN THE PRESENCE OF A BISUBSTRATE INHIBITOR |
4GRB | A: | CASEIN KINASE 2 (CK2) BOUND TO INHIBITOR |
4KWP | A: | CRYSTAL STRUCTURE OF HUMAN CK2-ALPHA IN COMPLEX WITH A BENZIMIDAZOLE INHIBITOR (K164) AT 1.25 A RESOLUTION |
4MD7 | E:; F:; G:; H: | CRYSTAL STRUCTURE OF FULL-LENGTH SYMMETRIC CK2 HOLOENZYME |